Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

2.0K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.0K
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

1.4K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.4K
Chemical Synapses01:26

Chemical Synapses

9.2K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
9.2K
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

1.1K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
1.1K
Muscle Contraction01:10

Muscle Contraction

7.0K
In skeletal muscles, acetylcholine is released by nerve terminals at the motor endplate—the point of synaptic communication between motor neurons and muscle fibers. The binding of acetylcholine to its receptors on the sarcolemma allows entry of sodium ions into the cell and triggers an action potential in the muscle cell. Thus, electrical signals from the brain are transmitted to the muscle. Subsequently, the enzyme acetylcholinesterase breaks down acetylcholine to prevent excessive...
7.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-term neuromuscular alterations during botulinum toxin treatment for chronic migraine.

Clinical neurophysiology practice·2026
Same author

Muscle-Specific Kinase Signaling and Its Therapeutic Potential.

Muscle & nerve·2026
Same author

MuSK antibodies differently affect the MuSK signaling cascade depending on valency and epitope specificity.

Journal of autoimmunity·2026
Same author

Serum inflammatory proteomic signatures define chronic inflammatory demyelinating polyneuropathy and inform on disease activity.

EBioMedicine·2026
Same author

Complement C3 inhibition restores myasthenia gravis AChR antibody-mediated muscle pathophysiology.

EBioMedicine·2026
Same author

Heterogeneity in the association between gut microbiota and insomnia moderated by Parkinson's disease status.

Frontiers in cellular and infection microbiology·2026

Related Experiment Video

Updated: Sep 15, 2025

Engineering and Characterization of an Optogenetic Model of the Human Neuromuscular Junction
11:07

Engineering and Characterization of an Optogenetic Model of the Human Neuromuscular Junction

Published on: April 14, 2022

2.5K

Cell models for studying myasthenia gravis.

Yu-Fang Huang1, Robyn L K Verpalen2, Anna Rostedt Punga1

  • 1Department of Medical Sciences, Clinical Neurophysiology, Uppsala University, Uppsala, Sweden.

International Review of Neurobiology
|July 17, 2025
PubMed
Summary
This summary is machine-generated.

This review explores cell models for Myasthenia Gravis (MG) research, focusing on their role in understanding autoimmune responses and neuromuscular dysfunction for developing new treatments.

Keywords:
Disease modelingFunctional readoutsIn vitro modelsMyasthenia gravisNeuromuscular junction

More Related Videos

Antigenic Liposomes for Generation of Disease-specific Antibodies
10:31

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

12.5K
Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells
09:39

Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells

Published on: July 29, 2016

15.5K

Related Experiment Videos

Last Updated: Sep 15, 2025

Engineering and Characterization of an Optogenetic Model of the Human Neuromuscular Junction
11:07

Engineering and Characterization of an Optogenetic Model of the Human Neuromuscular Junction

Published on: April 14, 2022

2.5K
Antigenic Liposomes for Generation of Disease-specific Antibodies
10:31

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

12.5K
Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells
09:39

Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells

Published on: July 29, 2016

15.5K

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Myasthenia Gravis (MG) is an autoimmune disorder affecting neuromuscular junctions.
  • Understanding MG pathophysiology requires accurate cell models.

Purpose of the Study:

  • To review current and potential cell-based models for Myasthenia Gravis research.
  • To assess their utility in preclinical studies.

Main Methods:

  • Review of existing literature on cell models for MG.
  • Discussion of muscle cells and co-culture models for neuromuscular junction (NMJ) formation.

Main Results:

  • Various cell models exist, each with specific strengths and limitations.
  • Methods for characterizing these models are crucial for their application.

Conclusions:

  • Cell models are essential for advancing Myasthenia Gravis research.
  • Future refinements will enhance their ability to model disease and test treatments.